IBIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IBIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
iBio's EPS without NRI for the three months ended in Dec. 2024 was $-0.48.
During the past 3 years, the average EPS without NRI Growth Rate was 63.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 56.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 31.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of iBio was 63.20% per year. The lowest was -62.00% per year. And the median was 8.70% per year.
For the Biotechnology subindustry, iBio's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, iBio's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where iBio's 3-Year EPS without NRI Growth Rate falls into.
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
iBio (NAS:IBIO) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Thank you for viewing the detailed overview of iBio's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Gary Sender | director | C/O SYNERGY PHARMACEUTICALS INC., 420 LEXINGTON AVE, NEW YORK NY 10020 |
Felipe Duran | officer: Interim CFO | 8800 HSC PARKWAY, BRYAN TX 77807 |
William D Clark | director | C/O GENOCEA BIOSCIENCES, INC., 100 ACORN PARK DRIVE 5TH FLOOR, CAMBRIDGE MA 02140 |
Martin Brenner | officer: Chief Scientific Officer | C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121 |
Evert B. Schimmelpennink | director | C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121 |
Isett Thomas Francis 3rd | director, officer: CEO and Executive Chairman | C/O IBIO INC. 600 MADISON AVENUE, SUITE 1601, NEW YORK NY 10022 |
Robert Matthew Lutz | officer: See Remarks | 900 NORTHBROOK DRIVE, SUITE 200, TREVOSE PA 19053 |
Randy Joe Maddux | officer: Chief Operating Officer | 2401 4TH AVENUE, SUITE #1050, SEATTLE WA 98121 |
Alexandra Kropotova | director | RIVER OAKS TOWER, 8800 HSC PARKWAY, BYRAN TX 77807 |
Linda Washington Armstrong | director | 8800 HSC PARKWAY, BRYAN TX 77807 |
John Delta | officer: Principal Accounting Officer | 8800 HSC PARKWAY, BRYAN TX 77807 |
Eastern Capital Ltd | 10 percent owner | 10 MARKET STREET, #773, CAMANA BAY, GRAND CAYMAN E9 KY1-9006 |
Robert L Erwin | officer: President | C/O IBIO, INC., 9 INNOVATION WAY, SUITE 100, NEWARK DE 19711 |
James P. Mullaney | officer: Chief Financial Officer | C/O IBIO, INC., 600 MADISON AVE., SUITE 1601, NEW YORK NY 10022 |
Carl Desantis | 10 percent owner | C/O CDS INTERNATIONAL HOLDINGS, 3299 NW SECOND AVE, BOCA RATON FL 33431 |
From GuruFocus
By PRNewswire • 12-05-2023
By GuruFocus Research • 02-13-2024
By GuruFocus Research • 02-13-2024
By GuruFocus News • 11-15-2024
By PRNewswire PRNewswire • 03-03-2023
By GuruFocus Research • 02-13-2024
By GuruFocus Research • 02-13-2024
By GuruFocus Research • 02-13-2024
By PRNewswire PRNewswire • 02-21-2023
By GuruFocus Research • 02-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.